Good morning, and welcome to the KKR Real Estate Finance Trust third quarter 2021 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Jack Switala. Please go ahead.
Great. Thanks, operator. Welcome to the KKR Real Estate Finance Trust earnings call for the third quarter of 2021. We hope that all of you and your families are safe and healthy. As the operator mentioned, this is Jack Switala. Today, I'm joined on the call by our CEO, Matt Salem, our President and COO, Patrick Mattson, and our CFO, Mostafa Nagaty. I would like to remind everyone that we will refer to certain non-GAAP financial measures on the call, which are reconciled to GAAP figures in our earnings release and in the supplementary presentation, both of which are available on the investor relations portion of our website. This call will also contain certain forward-looking statements which do not guarantee future events or performance. Please refer to our most recently filed 10-Q for cautionary factors related to these statements.
Before I turn the call over to Matt, I will provide a brief recap of our results. For the third quarter of 2021, we had GAAP net income of $32 million or $0.57 per share. Distributable earnings this quarter were $34.5 million or $0.62 per share, which is a record quarter for us, driven by net portfolio growth, benefits from in-place rate floors, prepayment income, and continued strong asset performance. Book value per share as of September 30, 2021, increased to $19.09, which includes the cumulative CECL impact of $1.07 per share as compared to $18.91 per share as of June 30. This will be the sixth consecutive quarter in which we have grown book value per share.
Finally, in mid-October, we paid a cash dividend of $0.43 per common share with respect to the third quarter. Based on yesterday's closing price, the dividend reflects an annualized yield of 7.6%. With that, I would now like to turn the call over to Matt.
Thank you, Jack. Good morning, everyone, and thank you for joining the call today. KREF delivered exceptionally strong results in the third quarter, with record distributable earnings of $0.62 per share. We also had a strong investing quarter, originating eight senior loans totaling $1.5 billion, bringing our funded portfolio to a record $5.8 billion, up 16% on a year-over-year basis. Our robust origination volumes are driven by a real estate credit team which has doubled in size over the last two years and is comprised of over 50 investment professionals today. We've expanded KKR Real Estate Credit capital sources as well, due in large part to KKR's acquisition of Global Atlantic.
Our real estate credit franchise expects to originate over $13.5 billion in loans in 2021, while, with KREF serving as the flagship senior transitional loan strategy. In short, we have become a one-stop solution for our institutional clients, and KREF benefits from this increased market activity. In addition, we continue to benefit from our real estate equity franchise as it expands with our latest U.S. opportunistic fund closing on $4.3 billion of committed capital. This scaled platform across the real estate spectrum of debt and equity provides differentiated access to information and market connectivity. In the third quarter, the eight loans we originated, totaling over $1.5 billion, included three multifamily loans, two office loans, and one loan in each of the life science, industrial, and hospitality sectors.
Seven of our eight loans were to repeat sponsors, which demonstrates the value of our franchise and the strength of our relationships. Similar to the second quarter, these loans were underwritten at an attractive low double-digit weighted average IRR, which is comparable with target returns pre-COVID. We believe these returns offer strong relative value given the risk profile of senior loans secured by institutional real estate owned by high-quality sponsors. One loan I'd like to highlight this quarter is a $520 million construction loan on a Class A LEED Gold office property to an experienced Seattle-based developer who has developed or acquired over 10 million sq ft. This large loan size created a favorable competitive dynamic, and we used multiple pockets of capital to secure the transaction.
KREF, using its first of the waterfall position, invested in 50% for approximately $260 million. The property is 100% pre-leased on a 16-year term to an investment-grade tenant. We were able to underwrite this to a projected IRR in the mid- to high teens. We continue to see robust activity and have approximately $1.1 billion of loans either closed or under exclusivity subsequent to quarter-end. We expect to be active in our historical segments of multifamily and select Class A office, along with certain newer growth segments such as life science and industrial, which now represent 7% and 5% of our funded portfolio as of the third quarter, respectively. Our portfolio composition remains consistent with previous quarters, and it's comprised predominantly of lightly transitional floating-rate senior loans.
71% of the portfolio is comprised of loans secured by multifamily and office properties. With respect to office, I'd highlight 89% of our office portfolio is comprised of Class A office properties, the majority of which is LEED certified. From a reporting perspective, we are now breaking out our exposure to life science, which was formerly included within the office property type segment and now represents 7% of the portfolio. Overall, performance remains strong, with interest collected on over 97% of the portfolio as of the third quarter. In summary, we achieved another strong quarter across the portfolio performance, earnings, and portfolio growth despite the active repayment environment. With that, I will turn the call over to Patrick.
Thank you, Matt, and good morning, everyone. As of quarter end, we increased our market-leading, fully non-mark-to-market financing to 81%, with the 19% remaining balance only subject to credit marks. KREF has continued to maintain mid-70s to low 80s% non-mark-to-market financing levels, similar to the way we were positioned at the start of the pandemic. At the quarter end, our debt-to-equity ratio and total leverage ratio were 1.8 times and 3.4 times, respectively. In terms of financing optimization, in Q3, we continued to add incremental non-mark-to-market financing capacity. First, we closed on a new $1.3 billion CRE CLO. The CLO features a two-year reinvestment period with an 84.25% investment-grade advance rate and attractive weighted average running cost of capital of LIBOR + 130 before amortized cost.
In conjunction with this transaction, we refinanced our first CLO, which was past its reinvestment period. The larger size of the new deal increased the amount of matched term, non-mark-to-market, and non-recourse financing. Second, we entered into a new $500 million bespoke term lending agreement, which provides us with asset-based financing on a non-mark-to-market basis with a matched term for up to five years. This differentiated financing is another example of the power of the broader KKR franchise and its impact on KREF. We have a robust quarterly asset review process and we evaluate every loan in the portfolio to assign a current risk rating. The current portfolio has a risk rating of 3.0 on a five-point scale, down slightly from 3.1 last quarter. 91% of our loans are now risk rated three or better, in line with last quarter.
With respect to certain loans, we are seeing improving trends in select properties, which may lead to positive credit momentum in other assets. As we've discussed on previous calls, we are nearing the next phase on our Portland retail loan. We intend to foreclose and to take ownership of the asset, enabling us to optimize value over the near and medium term. With our scaled and integrated U.S. real estate platform, we have the capabilities, relationships, and partners to execute this business plan to stabilize the property and optimize value for disposition at a future date. Upon taking title, which is targeted for the fourth quarter, we'll begin to prepare for a comprehensive redevelopment of the site, which we expect will include multiple uses, including residential and creative offices. We expect a more fulsome update on our next earnings call.
We still feel our $40 million CECL reserve is appropriate and therefore expect little impact to GAAP earnings and book value. However, upon foreclosure, we will recognize a loss through our cash metric of distributable earnings. This quarter, we received approximately $935 million of repayments, and as previously indicated, we would expect another $1 billion in repayments in Q4 before repayment levels begin to normalize in the first half of 2022. Our net positive fundings in the third quarter, combined with our current commitments and forward pipeline, give us confidence in our ability to continue to grow the portfolio. In the near term, we also expect to con tinue to benefit from remaining in place LIBOR floors and elevated effective net interest margins. This will decrease as the portfolio continues to transition to new loans originated at Spot LIBOR.
Finally, KREF finished the quarter with a strong liquidity position of over $510 million. This total included over $307 million of cash and $185 million in undrawn corporate revolver capacity available to us. We also have $374 million of unencumbered and unpledged loans as of quarter end that can be levered to provide additional liquidity. In summary, a record quarter with distributable earnings of $0.62 per share, covering our forty-three cent dividend by over 1.4 times. Robust originations across eight loans totaling $1.5 billion and an additional pipeline of approximately $1.1 billion under exclusivity or close subsequent to quarter end. We grew the funded portfolio by over $200 million to a record $5.8 billion, which compares to $5 billion at the start of 2021.
Lastly, we incrementally added match term financing, which contributed to a market-leading 81% non-mark-to-market asset financing as of September 30. Thank you for joining us today. Now we're happy to take your questions.
Thank you. We will now begin the question and answer session. To ask a question, you may press star then one on your telephone keypad. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two. At this time, we will pause momentarily to assemble our roster. The first question will be from Jade Rahmani with KBW. Please go ahead.
Thank you very much for taking the questions. Should we anticipate early prepayment income going forward, and particularly in the fourth quarter since you noted $1 billion of repayments?
Good morning, Jade. It's Patrick. I'll address that. Yes, I think, you know, if you look at this quarter, where we had $6.4 million come through, that was a combination of acceleration of OID and prepayment fees. The sort of breakdown of that was, $4.1 of that was prepayment income. Obviously, that's difficult to sort of model. However, we do expect the OID acceleration just given generally we're funding lighter transitional loans. So any payoff prior to the initial maturity date results in acceleration of, you know, of OID. Just for context, you know, in the first and second quarter where we had really low levels of repayments, that equated to about $0.02 in those quarters. This quarter it was more elevated.
We saw $0.04 come through from the OID acceleration. That gives you some framework for, you know, what we might expect in the fourth quarter and beyond.
You're still expecting to grow the portfolio on a net funded basis in the fourth quarter?
Yes, I believe so. I mean, if you look at, you know, where we are just even in October here, and we give you the, you know, activity subsequent to quarter end. We had a initial funding of $280 million. We had repayments of a $100 million. We're on track to continue to, as we have in, you know, each of the last three quarters, increase, you know, the portfolio size, on a net funded basis.
Thank you. Just in terms of ROEs, peers also reported today and in that, quite a sharp drop in incremental yield. Are you seeing consistent ROEs? Can you give some context around loan yields and spreads? Yeah, just a comment on the ROE profile. Thanks for taking the questions.
Sure, Jade. I'll jump in on that. It's Matt, and thanks for joining the call and for the questions. You know, let's start at asset yield. I'd say that, first of all, the market's been pretty consistent over the last few quarters. The tight end of the range. So think about a very straightforward multifamily lease-up play, institutional sponsorship, new asset. Those are in the, call it, very high twos, LIBOR plus, you know, very high twos. And the widest end of what we're doing is around, call it, all in 4% type of coupon. So that 100 basis point range is similar to, I think, what we've discussed on, you know, the last couple of calls.
When you translate that into ROE, we're generating returns in the, call it, 11%-13% range on a gross basis. Pretty similar to where we were pre-COVID. I'd say the market is pretty attractive from a, certainly from a relative value perspective, when we look around the world and think about where interest rates are and where other fixed income products are. We're pretty happy with what we're seeing and the stability in the current market.
Thank you very much.
Sure.
The next question is from Tim Hayes from BTIG. Please go ahead.
Hey, good morning, guys. Congrats on the record results. First question here. Just on the new bespoke lending agreement you entered into this quarter, can you touch on a little bit more of the terms and just maybe even from a high level, just how the cost and advance rate compare to other facilities you have and if there are any other types of like unique covenants to be aware of. Just trying to understand, you know, how favorable or maybe even less favorable the terms of these agreements are in order to get that kinda non-mark-to-market aspect of it.
Sure, Tim, it's Patrick. Good morning. This facility, you know, similar to some of the bespoke facilities that we've executed in the past, it's a bilateral facility. It has an initial revolving period, and for each loan that we put on the facility, we can get matched financing up to five years. We do have the revolving aspect, so as loans pay off, we can reset and put new loans with new five-year, you know, matched term financing. As we mentioned, it's non-mark-to-market, so that's consistent with some of our other bespoke facilities. It has a cost of financing and we quote in the 10-Q, a range of the existing assets that are on the facility of 165-175.
I think as you look across our facilities, it's right down the fairway, I think, in terms of cost. From a leverage standpoint, again, consistent with how we borrowed on a non-mark-to-market basis, it's driven by the underlying collateral that's being put onto the facility, but the financing leverage ranges from anywhere from 75%-85% depending on the asset. Right down the fairway, but clearly a unique facility. To our knowledge, this counterparty does not have an existing facility with any other financial institution like ours, and really was, you know, another example of the KKR platform coming and sort of really bearing fruit in a meaningful way, and allowing us to, you know, to continue to increase this capacity.
No, that's helpful, Patrick. Thanks for the color there, and definitely seems like, yeah, doesn't hurt having KKR as your sponsor there for that exact reason. So, you know, between the new lending facility, cash on hand, you know, it seems like liquidity position and repayments, of course. $1 billion repayments expected this upcoming quarter. Seems like your liquidity position is pretty strong here. Just don't wanna put words in your mouth, though. Like, how do you feel about your liquidity position here, given that the pipeline is very strong? We did see leverage tick up a little bit last quarter, and it seems like you continue to expect net portfolio growth.
Just wondering if it makes sense in your eyes to look at potentially doing another type of securitization or any other types of financing to bolster the capital structure.
Yeah, sure, Tim. I mean, I think certainly from a liquidity position, we feel really good. If you look at the different forms of liquidity, we've got the revolver, obviously a key to us, you know, sort of managing cash on the, on the balance sheet. As I mentioned, we've got this new facility that we put in place. We closed on the CLO, so as assets pay off of that, we'll have capacity to, you know, to refinance there. We feel really well positioned. You know, additionally, we also quoted in the supplemental, we have $374 million of unencumbered assets that are sitting on the balance sheet. Those are assets that we could pledge to facilities, and borrow additional capital against that.
We feel well positioned to, you know, manage the pipeline, which, as Matt indicated, you know, is pretty robust at $1.1 billion, and we think the opportunity set behind that is also pretty great. You know, I think we feel really good to be able to fund the commitments that we've got and also capitalize on opportunities that may come up.
Got it. Like, I guess part B to that question, though, Patrick is, you know, how given your current capital base, how big do you see the portfolio getting before you need to maybe start considering external capital?
I think as we indicated before, with our existing equity, around $6 billion is probably the total funded size. We're kind of in that area sort of plus or minus. Obviously, we've got, as we've indicated, a decent amount of repayments that we're expecting. We think we're gonna match off with those fairly well with our pipeline. With existing-
Mm-hmm.
equity, we think about $6 billion.
Okay. Got it. Yeah, I think you've mentioned that before, so thanks for confirming. Last question from me. You know, it's no surprise that, you know, competition has been pretty strong, and we've seen a lot of capital raising across your peers and private debt funds and other non-traditional sources. I think we recently saw one of the largest CRE brokers take a large stake in a multifamily lender, and I think maybe what they're doing is more on the agency side. It might not be directly overlapping with you.
Just curious, you know, when you see headlines like that, if it gives you pause that you continue to see new players enter the market or that the space might be getting too crowded or, you know, does the KKR model just stand the test of time even in these kind of more competitive parts of the cycle?
Hey, Tim, it's Matt. I'll jump in there. Thanks for the question. You know, certainly it's a competitive market today. I mean, you think about the low interest rate environment, the thirst for yield, and the attractive, you know, relative value, you know, that we're seeing in the market. You know, you'd expect to see new entrants. You'd expect to see, you know, new capital accessing the sector. I would say locally, we haven't seen any new competitors in our space. Certainly our competitors have capital and capital availability, and that's been the case for most of our existence and certainly over the last few quarters.
I think that where we sit in terms of our franchise, our client relationships, the size of the loans that we participate in, and the efficiency of our cost of capital, you think about, you know, our liabilities that Patrick just mentioned, we feel really good about our competitive positioning in the market. Like I said, we haven't really seen new entrants in our particular segment of the market. You know, we're always cautious and disciplined as we approach the market. You know, right now, we're pretty excited about what we're seeing in terms of the investment opportunity set.
Okay. Got it. Well, thanks for the comments, Matt and Patrick. Appreciate it.
Thanks, Tim.
Thanks, Tim.
The next question will be from Stephen Laws from Raymond James. Please go ahead.
Hi, good morning. A couple of things I wanna touch on and maybe a follow-up or two to some previous questions. I guess first around, you know, distributable earnings clearly outpacing the dividend by a significant margin. You know, any thoughts at, you know, what adjustments we may need to make to distributable earnings to get a good proxy for REIT taxable income? Is there any financial impact around the foreclosure on the portfolio, excuse me, the Portland retail asset that may reduce your distribution requirements for the year?
Thanks, Stephen. It's Matt. I can take that one. Yeah, I think specifically as it relates to the Portland retail asset, you know, that will impact our DE as, you know, as Patrick mentioned. You know, when you think about the impact, you should think about that in the context of the CECL reserve, you know, that we mentioned on the call. You know, in terms of how that relates to the dividend, obviously the board, you know, will discuss that at an upcoming meeting. But we really view that as a one-time event and not a recurring item.
Great. Around your pipeline and really geographic concentration. You know, it looks like your exposure in Illinois was down noticeably, Texas and California up. Is that kind of coincidental, or is that a conscious decision to move out of the Illinois market and focus more on some other areas? Can you talk about you know, the pipeline and kind of how you expect geographic exposure to shift in the coming quarters?
Sure. Yeah. I'm happy to take that. Some of it is a little bit idiosyncratic. As you know, we make, you know, larger loans, and so any one loan repayment or origination can cause a quarter of skew, if you will. I think the Illinois came down because we had one large repayment on the multifamily side. Obviously the other areas you're mentioning were in some of our origination numbers. I think overall, we haven't really changed our posture in terms of what we're targeting. Larger markets, we still like larger markets. We still like them because they're more liquid, they're more transparent.
At the same time, we are seeing a tremendous amount of activity, you know, in the southeastern states and some of the, you know, lower cost states. We have been very active in those areas as well, especially as it relates to, you know, office lending, yeah, specifically as it relates to office lending. No real change in the posture, but you may see a little bit of noise here and there, given the size of the loans.
Great. Last question, just wanna touch on life sciences. You know, you guys I think broke that out, but how has that changed maybe over, say, a year-over-year? I know KKR has some advantages there, that you have resources that give you some expertise. You know, can you talk about, and I think you've additionally closed another life sciences loan subsequent to quarter end. You know, can you talk about the focus there and what the sponsor brings to the table in being able to underwrite those loans, which can be a little unique versus other types of office loans? You know, at 8%, you know, how big of a bucket is that something you could see that growing to over the next, you know, four to eight quarters?
Yeah. Let me, I'll take that one. It's Matt again. A couple of things. I think first you asked what's changed. I think that the biggest change has been a tremendous increase in tenant demand for space. That's really what's driving all of this activity. Obviously we're responding to that both on the equity side of our business where we own and operate life science properties and clearly, as you mentioned, on the lending side where we lent on a property this quarter and subsequent to quarter end as well. You know, as we approach this particular sector, I think it's similar to how we approach other sectors with a slightly higher bar.
You know, we think that there is a real technical aspect to you know owning and creating and operating these buildings. When we think about sponsor and we think about location, we're, I'd say, much more disciplined in the life science space and have a much higher bar than we would in you know a more generic or traditional you know asset class. What we're seeing in the portfolio, again, across equity and debt, is quite tremendous in terms of the activity and the leasing volume that we're seeing. It is a pretty, we think, a very good sector with a lot of tailwinds.
You know, in terms of where it can grow from a portfolio size perspective, you know, I don't have a number or kind of a red line that you know, we wouldn't cross. Certainly, it's within this context could go up a little bit, you know, more from here. You know, if you think about its overall positioning in the market, it's not, you know, a tremendously large part of the overall real estate market. You know, we'll probably do a little bit more here and see what opportunities are available, but I don't expect this to be an extremely large portion of the portfolio.
Great. Matt, Patrick, I appreciate the comments this morning.
Thanks, Stephen.
The next question is from Don Fandetti from Wells Fargo. Please go ahead.
Two questions. I guess first, with the Fed looking like they're gonna taper, do you expect any, you know, material changes in the commercial real estate markets that, you know, you'd position for? And then secondly, can you comment on, you know, your appetite to put capital to work in New York City as it recovers?
Hey, Don. Matt, yeah, I can take that. Thank you for the question. I guess first of all, as the Fed tapers, you know, I don't think we see a very large impact to real estate. You know, clearly, that path has to be navigated appropriately. Real estate, like other sectors, could get impacted by, you know, potential volatility in rates and broader markets in reaction to, you know, potential rate moves. I don't think that's our house view here. We, you know, we think that it's natural for rates to go up as the economy continues to rebound. And we still think real estate is a pretty attractive asset class.
You know, when you think about some of the inflationary pressures you may see on the market, you know, we do think that the combination of real estate equity, kind of an inflation hedge as well as the yield play, could be quite attractive investment in this type of market environment. That's the first thing I'd say. You know, on the appetite to invest in New York City, it's the largest market in the United States. Still has a lot of liquidity in certain sectors. Certainly we're looking at opportunities in New York. You know, we will continue to lend in New York.
We are much more cautious, as we have been historically, on some of the sectors that you would expect. When you think about Class B or more generic office space, that is gonna be challenged, we think. At the same time, I think there's a real demand for high quality Class A office space. On the multifamily side, we've seen that come back and rebound, you know, quite strongly. It's a sector we'll continue to, you know, continue to look at as we have. We do think New York's an investable market. You've got to pick your spots, as always. We'll continue to look at it.
Thanks.
Again, if you have a question, please press star then one. The next question will be from Rick Shane with JP Morgan. Please go ahead.
Good morning, everybody, and thanks for taking my questions. When we look at the interest rate sensitivity and compare it to the forward curve, it suggests that there's probably somewhere between 50 and 75 basis points of ROE compression, if we were just to follow the forward curve. Now, I realize what's actually happening is that the portfolio is recasting at a slightly or not slightly, but at a lower ROE, as the floors run off and spreads tighten. I'm curious, when you look ahead to 2022, what is a reasonable ROE and maybe ROE in the context of LIBOR plus?
Rick, good morning. It's Patrick. Thanks for that question. When we think about return and we think about sort of LIBOR, we're obviously focused on where spreads are, but what we ultimately care about is all-in coupon. If you look at our all-in coupons today, they're almost entirely made up of spread. LIBOR is obviously compressed to such a level that, you know, in eight basis points, it's not a contributor to ROE on new loans. If you forecast out the forward curve or assume that at some point in time we're in a higher rate environment, that's going to give us a positive return on those assets because our asset coupon will increase, our liability coupon will increase, but will be offset by the asset side.
We would expect that there's an opportunity to generate higher returns, you know, on those existing loans. If you look at page 19 of the supplemental, we included an additional sort of, you know, bar graph. This is our sensitivity to LIBOR.
What we tried to show here was how the portfolio is transitioning as some of our higher LIBOR floor loans are paying off, and we're replacing those with loans that are at spot LIBOR. As you can see, quarter-over-quarter, we have less sensitivity to higher rates. As we get more repayments and as we recycle into more loans at these lower LIBOR rates, we expect at some point that change in LIBOR, the higher LIBOR rates to lead to positive earnings benefit, you know, down the road. The portfolio is shifting. We expect that, you know, over the course of the next couple of quarters, this graph will start to look different and we'll ultimately be positioned for, you know, higher rates and get a positive benefit as a result.
Yes. Look, this is exactly what I was looking at, sort of doing that math. I think you're right that the portfolio is recasting in the asset sensitivity that's intrinsic in these portfolios as sort of being reestablished as those floors run off. Should we think about the sort of potential worst case compression as being that LIBOR 1% scenario? Because at that point, you'll basically have experienced all of the transition of the existing floors.
In the near term, you know, in the near term, I don't think, you know, our forecast is, you know, for a 1% LIBOR. While we show that as a sensitivity on this page, the reality is that we expect the portfolio to transition, you know, at a faster pace. By the time we get to a scenario where we're in that context, we don't expect that this is, you know, the composition of the portfolio. Obviously, if it's set overnight to this level, this would be the impact, right, if it were sustained there for a quarter. That's not our base case in terms of, you know, rate projections.
Understood. I actually meant this more theoretically. When you look at the portfolio with 50% now subject to floors above 75 basis points, which means that less than 50% has less than 75 basis points in a weighted average floor of 1%. What I'm suggesting is this sort of headwind from the floor recast is pretty similar potentially to this 1% LIBOR scenario.
Right. I think that's right. I mean, I think over time, and you've seen it, as you sort of had followed, you know, quarter-over-quarter, this LIBOR floor, you know, continues to compress down the percentage, right, of loans. We keep dropping this sort of floor number. We're showing half of it at 75 basis points. Would anticipate, right, as we get through fourth quarter, if we show that as half the portfolio, again, that's gonna size down, you know, considerably so. I think it's trending all in that direction that you would anticipate. It's not, maybe not, you know, not surprising the loans that are sort of repaying or the loans that have realized on their business plans are the ones that are more seasoned and obviously have, you know, the higher LIBOR floors.
Great. Thank you for the transparency on this slide. It's very helpful. Thanks for taking my questions.
Thanks, Rick.
Ladies and gentlemen, this concludes our question-and-answer session. I would like to turn the conference back over to Jack Switala for any closing remarks.
Great. Thanks for joining, everyone. Please reach out to me or the team if you have any questions. Stay dry out there.
Thank you. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.